AIRM 42.95 Air Methods Corp $AIRM Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
AIRM 42.95 Air Methods Corp $AIRM Hit a 52 week low of 42.16 Closing the day 11/07/14 at 42.95 -3.69 -7.91% With a day low of 42.16 and a total volume of 1,892,650.

AIRM Recent Posts: http://investorshangout.com/Air-Methods-Corp-AIRM-53268/

AIRM Air Methods Corp Recent Headline News

Shares of AIRM Down 17.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 11:12AM CST
SmarTrend identified a Downtrend for Air Methods (NASDAQ:AIRM) on September 22nd, 2014 at $53.96. In approximately 2 months, Air Methods has returned 17.79% as of today's recent price of $44.36.
AIRM: 42.95 (-3.69)

Air Methods Corp.'s Choppy Quarter
Todd Campbell, The Motley Fool - Motley Fool - Fri Nov 07, 10:07AM CST
Source: Air Methods Air Methods shares fell by nearly 20% in October when it cut its third-quarter earnings per share outlook to between $0.83 and $0.87 -- far south of analysts' $1.07 estimates. Fortunately, Air Methods third-quarter results...
AIRM: 42.95 (-3.69)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
BWEN: 6.64 (+0.05), AIRM: 42.95 (-3.69), CPF: 19.17 (-0.03), BIO: 110.60 (-0.50), BALT: 3.28 (-0.17)

Air Methods misses 3Q profit forecasts
Automated Insights - Thu Nov 06, 4:05PM CST
ENGLEWOOD, Colo. (AP) _ Air Methods Corp. (AIRM) on Thursday reported earnings of $33.7 million in its third quarter.
AIRM: 42.95 (-3.69)

Air Methods Reports 3Q2014 Results and 4Q2014 Update
GlobeNewswire - Thu Nov 06, 3:03PM CST
Air Methods Corporation (Nasdaq:AIRM) reported results for the quarter ended September 30, 2014. Revenue increased 10% to $277.8 million from $252.4 million in the year-ago quarter. For the nine-month period, revenue increased 15% to $759.4 million, up from $657.8 million in the prior-year nine-month period. For the quarter, net income decreased 5% to $33.7 million, or $0.90 per diluted share, as compared with 2013 third quarter net income of $35.6 million, or $0.91 per diluted share. Net income for the nine-month period increased 50% to $73.4 million, or $1.91 per diluted share, compared to $49.1 million, or $1.25 per diluted share, for the prior-year period. Financial results for the three and nine months ended September 30, 2014 include operations associated with the Company's acquisition of Helicopter Consultants of Maui, LLC (doing business as Blue Hawaiian Helicopters) and certain of its affiliates (collectively, Blue Hawaiian), on December 13, 2013. Revenue generated from Blue Hawaiian during the quarter and nine months ended September 30, 2014 was $15.0 million and $42.5 million, respectively.
AIRM: 42.95 (-3.69)

12.6% Return Seen to Date on SmarTrend Air Methods Call (AIRM)
Comtex SmarTrend(R) - Fri Oct 31, 9:57AM CDT
SmarTrend identified a Downtrend for Air Methods (NASDAQ:AIRM) on September 22nd, 2014 at $53.96. In approximately 1 month, Air Methods has returned 12.62% as of today's recent price of $47.15.
AIRM: 42.95 (-3.69)

Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
AIRM: 42.95 (-3.69), CBR: 3.35 (+0.05), CCE: 42.72 (-0.14), AIR: 26.37 (-0.10), AEGN: 19.28 (+0.12)

Air Methods Shares Down 15.5% Since SmarTrend's Sell Call (AIRM)
Comtex SmarTrend(R) - Fri Oct 24, 9:23AM CDT
SmarTrend identified a Downtrend for Air Methods (NASDAQ:AIRM) on September 22nd, 2014 at $53.96. In approximately 1 month, Air Methods has returned 15.49% as of today's recent price of $45.60.
AIRM: 42.95 (-3.69)

Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
EMKR: 5.20 (+0.02), VBFC: 18.65 (-1.32), AIRM: 42.95 (-3.69), JAKK: 6.51 (-0.03), ANGI: 6.61 (+0.16), BDBD: 8.76 (+0.17), LAKE: 13.29 (+0.42), ORPN: 5.35 (+0.15), SUSQ: 9.83 (+0.05), AREX: 10.73 (+1.88), CREE: 32.62 (+0.13)

Why Air Methods Corp. Stock Is Grounded
Sean Williams, The Motley Fool - Motley Fool - Thu Oct 23, 1:13PM CDT
This article originally appeared as part of ongoing coverage in our premium   Motley Fool Stock Advisor  service...we hope you enjoy this complimentary peek! What's happening: Shares of Air Methods , a provider of air medical emergency...
AIRM: 42.95 (-3.69)

Air Methods Provides Update on 3rd Quarter Results
GlobeNewswire - Wed Oct 22, 3:01PM CDT
Air Methods Corporation (Nasdaq:AIRM), the global leader in air medical transportation, provided an update on third quarter results. While community-based patient transports for the third quarter 2014 increased 7% to 15,789 from the prior-year quarter, patients transported for community bases in operation greater than one year decreased an estimated 375 transports, or 3%. Weather cancellations for these same bases increased by an estimated 59 transports compared with the prior-year quarter.
AIRM: 42.95 (-3.69)

MedAssets Closes Sg2 Acquisition for $142M but Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 10:30AM CDT
MedAssets, Inc. (MDAS) expects the Sg2 business to prove slightly accretive in calendar 2015 on a stand-alone basis, and the company may increase its investment to drive additional long-term growth opportunities.
AIRM: 42.95 (-3.69), EVHC: 32.49 (-1.21), MDAS: 20.22 (-0.47), ICLR: 52.61 (+0.34)

Healthways-Gallup Unveil Well-Being Report; US Ranks 12th - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 12:30PM CDT
Healthways Inc. (HWAY), and leading management consulting firm, Gallup, released their inaugural analysis of the "State of Global Well-Being" which was initiated in 2013.
AIRM: 42.95 (-3.69), EVHC: 32.49 (-1.21), HWAY: 15.14 (-0.19), ICLR: 52.61 (+0.34)

Insider Trading Alert - RTN, CSCO And AIRM Traded By Insiders
at The Street - Thu Sep 18, 9:45AM CDT
Stocks with insider trader activity include RTN, CSCO and AIRM
AIRM: 42.95 (-3.69), RTN: 104.36 (-0.35), CSCO: 25.33 (+0.07)

Air Methods Has Returned 10.7% Since SmarTrend Recommendation (AIRM)
Comtex SmarTrend(R) - Wed Sep 17, 9:32AM CDT
SmarTrend identified an Uptrend for Air Methods (NASDAQ:AIRM) on June 11th, 2014 at $49.95. In approximately 3 months, Air Methods has returned 10.72% as of today's recent price of $55.30.
AIRM: 42.95 (-3.69)

Healthways-UnitedHealthcare Extend SilverSneakers Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 9:10AM CDT
UnitedHealthcare extended its relationship with Healthways Inc. (HWAY) to continue offering SilverSneakers Fitness Program to its Medicare Members through 2017.
AIRM: 42.95 (-3.69), UNH: 93.61 (-2.60), HWAY: 15.14 (-0.19), ICLR: 52.61 (+0.34)

Air Methods Up 14.7% Since SmarTrend Uptrend Call (AIRM)
Comtex SmarTrend(R) - Tue Sep 09, 5:13PM CDT
SmarTrend identified an Uptrend for Air Methods (NASDAQ:AIRM) on June 11th, 2014 at $49.95. In approximately 3 months, Air Methods has returned 14.75% as of today's recent price of $57.31.
AIRM: 42.95 (-3.69)

MedAssets Extends Relationship with LHP Hospitals but Slips - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 12:40PM CDT
Both MedAssets (MDAS) and LHP will work together to implement a unique approach to sustain improvements in financial, operational and clinical performance under the extended agreement.
AIRM: 42.95 (-3.69), Q: 57.21 (-0.74), MDAS: 20.22 (-0.47), ICLR: 52.61 (+0.34)

Why Intrexon (XON) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 7:36AM CDT
Intrexon is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
AIRM: 42.95 (-3.69), XON: 21.15 (+0.21), CRL: 63.36 (-0.37), ICLR: 52.61 (+0.34)

Air Methods Corp. (AIRM) Stock Research Links

AIRM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading